Metformin Reverses Prostate Cancer Resistance to Enzalutamide by Targeting TGF-β1/STAT3 Axis-Regulated EMT.

2017

Metformin reverses prostate cancer resistance to enzalutamide by targeting TGF- β 1/STAT3 axis-regulated EMT

Keywords:

Correction
Source
Cite
Save
Machine Reading By IdeaReader

49

References

53

Citations